← Back
$AGIO All transactions

AGIOS PHARMACEUTICALS, INC.

M 10b5-1 Plan

$ Value

$0

Shares

3,302

Price

$0

Filed

Oct 29

Insider

Name

Gheuens Sarah

Title

Chief Medical Officer

CIK

0001881190

Roles

Officer

Transaction Details

Transaction Date

2025-10-27

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

28,784

Footnotes

Includes 456 shares purchased through the Company's employee stock purchase plan. | This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. | The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $43.77 to $44.13. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | This option was originally granted on March 1, 2023 for the purchase of 44,000 shares of common stock. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter.

Filing Info

Accession No.

0001439222-25-000111

Form Type

4

Issuer CIK

0001439222

Gheuens Sarah's History

Date Ticker Type Value
2026-04-02 AGIO M $0
2026-04-02 AGIO $102K
2026-04-02 AGIO M $0
2025-12-30 AGIO M $0
2025-12-30 AGIO $79K
2025-12-30 AGIO M $0
2025-11-11 AGIO M $61K
2025-11-11 AGIO $107K
2025-11-11 AGIO M $0
2025-10-30 AGIO M $5K

Other Insiders at AGIO (90d)

Insider Bought Sold Last
Goff Brian
Chief Executive Officer
$662K 2026-04-02
Jones Cecilia
Chief Financial Officer
$109K 2026-04-02
Gheuens Sarah
Chief Medical Officer
$102K 2026-04-02
Burns James William
Chief Legal Officer
$114K 2026-04-02
Milanova Tsveta
Chief Commercial Officer
$113K 2026-04-02
Viswanadhan Krishnan
Chief Corp Dev & Strategy
$103K 2026-04-02